Search - tctmd.com

Displaying 661 - 680 of 2106

Sort: Relevancy | Date

News Daily News

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Yael L. Maxwell

May 21, 2020

News Features

Cardiology After COVID-19: Physicians Predict Lasting Change

Yael L. Maxwell

May 20, 2020

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

News Daily News

New AHA Guidance on Hospital VTE Stresses Risk Assessment, Standardization

Yael L. Maxwell

May 12, 2020

News Daily News

Takotsubo Rising During COVID-19? Stress, Viral Triggers Need Attention

Yael L. Maxwell

May 08, 2020

News Daily News

Atrial Septal Aneurysm, Not Shunt Size, Tied to Recurrent PFO-Related Stroke

Yael L. Maxwell

May 04, 2020

News Daily News

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Yael L. Maxwell

April 28, 2020

News Daily News

Takotsubo Snapshot Reveals Some Surprises: InterTAK Registry

Yael L. Maxwell

April 27, 2020

News Daily News

No ‘Obesity Paradox’: BMI and Infarct Size Not Linked in STEMI

Yael L. Maxwell

April 22, 2020

News Daily News

COVID-19’s Lopsided Impact on Minorities Should ‘Ignite’ Reform, Experts Say

Yael L. Maxwell

April 20, 2020

News Daily News

In the Setting of PFO, Time to Retire ‘Cryptogenic’ Stroke

Yael L. Maxwell

April 16, 2020

News Features

Thanks to COVID-19, Cardiology Fellows Gain Unexpected Skills but Risk Losing Others

Yael L. Maxwell

April 16, 2020

News Daily News

Echo During COVID-19? New Advice Weighs Doctor Safety, Patient Needs

Yael L. Maxwell

April 13, 2020

News Conference News ACC 2020

Sodium Nitrite Fails to Improve Survival in Out-of-Hospital Cardiac Arrest

Yael L. Maxwell

April 08, 2020

News Conference News ACC 2020

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Yael L. Maxwell

April 06, 2020

Hope for these hard-to-treat patients: more than half saw ≥ 50% decrease at 24 weeks, regardless of LDL receptor function.

News Conference News ACC 2020

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Yael L. Maxwell

April 01, 2020

News Conference News ACC 2020

PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery

Yael L. Maxwell

March 31, 2020

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

News Conference News ACC 2020

Genotype-Based P2Y12 Prescribing Post-PCI Falls Short in TAILOR-PCI

Yael L. Maxwell

March 28, 2020

Advertisement

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Cardiology After COVID-19: Physicians Predict Lasting Change

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

New AHA Guidance on Hospital VTE Stresses Risk Assessment, Standardization

Takotsubo Rising During COVID-19? Stress, Viral Triggers Need Attention

Atrial Septal Aneurysm, Not Shunt Size, Tied to Recurrent PFO-Related Stroke

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Takotsubo Snapshot Reveals Some Surprises: InterTAK Registry

No ‘Obesity Paradox’: BMI and Infarct Size Not Linked in STEMI

COVID-19’s Lopsided Impact on Minorities Should ‘Ignite’ Reform, Experts Say

In the Setting of PFO, Time to Retire ‘Cryptogenic’ Stroke

Thanks to COVID-19, Cardiology Fellows Gain Unexpected Skills but Risk Losing Others

Echo During COVID-19? New Advice Weighs Doctor Safety, Patient Needs

Sodium Nitrite Fails to Improve Survival in Out-of-Hospital Cardiac Arrest

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Evinacumab Cuts LDL Cholesterol in Homozygous FH

PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Genotype-Based P2Y12 Prescribing Post-PCI Falls Short in TAILOR-PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content